Because Bcl-2 family members have been shown to be important regulators of malignant progression in many cancers [42], we used western blot analysis to detect the expression of Bcl-2 family proteins in MM cells isolated from patient samples and the U266 and RPMI 8226 cell lines after treatment with WEV and WEV+NP. Here, BCL2 is linked to Miyoshi myopathy.